SPI
17.542,28
PKT
+155,74
PKT
+0,90
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.08.17 | Novartis Neutral | UBS AG | |
| 28.08.17 | Novartis buy | Kepler Cheuvreux | |
| 28.08.17 | Swiss Re Underperform | BNP PARIBAS | |
| 24.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.08.17 | Holcim Hold | Deutsche Bank AG | |
| 16.08.17 | Zurich Insurance Underperform | Macquarie Research | |
| 16.08.17 | Swiss Re overweight | Morgan Stanley | |
| 15.08.17 | Swiss Re Verkaufen | Norddeutsche Landesbank (Nord/LB) | |
| 15.08.17 | UBS buy | HSBC | |
| 15.08.17 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.08.17 | Zurich Insurance Neutral | UBS AG | |
| 14.08.17 | Swiss Re Sell | UBS AG | |
| 14.08.17 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 14.08.17 | Swiss Re Reduce | Commerzbank AG | |
| 14.08.17 | Zurich Insurance Outperform | Credit Suisse Group | |
| 11.08.17 | Peach Property Group Kaufen | SRC Research GmbH | |
| 11.08.17 | Zurich Insurance kaufen | DZ BANK | |
| 11.08.17 | Holcim Neutral | UBS AG | |
| 11.08.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 11.08.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 11.08.17 | UBS buy | HSBC | |
| 11.08.17 | Givaudan Underweight | Barclays Capital | |
| 11.08.17 | UBS buy | HSBC | |
| 11.08.17 | UBS buy | Goldman Sachs Group Inc. | |
| 10.08.17 | Zurich Insurance Hold | S&P Capital IQ | |
| 10.08.17 | Zurich Insurance Neutral | UBS AG | |
| 10.08.17 | UBS buy | Citigroup Corp. | |
| 10.08.17 | UBS buy | Citigroup Corp. | |
| 09.08.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 08.08.17 | Holcim buy | Citigroup Corp. | |
| 08.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 07.08.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 07.08.17 | UBS neutral | RBC Capital Markets | |
| 07.08.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 07.08.17 | Swiss Re kaufen | DZ BANK | |
| 07.08.17 | Swiss Re Sell | UBS AG |